Cargando…

COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections

Background: To determine the effect of disease-modifying therapies (DMT) on humoral postvaccine seroconversion, long-term humoral response, and breakthrough COVID-19 infections in persons with multiple sclerosis (PwMS) and other neuroinflammatory disorders. Methods: A total of 757 PwMS and other neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakimovski, Dejan, Zakalik, Karen, Awan, Samreen, Kavak, Katelyn S., Pennington, Penny, Hojnacki, David, Kolb, Channa, Lizarraga, Alexis A., Eckert, Svetlana P., Sarrosa, Rosila, Vineetha, Kamath, Edwards, Keith, Weinstock-Guttman, Bianca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146267/ https://www.ncbi.nlm.nih.gov/pubmed/35632451 http://dx.doi.org/10.3390/vaccines10050695

Ejemplares similares

Tixagevimab and Cilgavimab (Evusheld™) Prophylaxis Prevents Breakthrough COVID-19 Infections in Immunosuppressed Population: 6-Month Prospective Study
por: Jakimovski, Dejan, et al.
Publicado: (2023)

A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2022)

Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment
por: Jakimovski, Dejan, et al.
Publicado: (2021)

No association between variations in extracranial venous anatomy and clinical outcomes in multiple sclerosis patients over 5 years
por: Gandhi, Sirin, et al.
Publicado: (2019)

Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases
por: Hemond, Christopher C., et al.
Publicado: (2021)

Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives
por: Ozel, Osman, et al.
Publicado: (2019)

Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2019)

Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes
por: Jakimovski, Dejan, et al.
Publicado: (2021)

The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging
por: Guan, Yi, et al.
Publicado: (2019)

Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic
por: Jakimovski, Dejan, et al.
Publicado: (2022)

Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Laquinimod Therapy in Multiple Sclerosis: A Comprehensive Review
por: Kolb-Sobieraj, Channa, et al.
Publicado: (2014)

Retinal Blood Vessel Analysis Using Optical Coherence Tomography (OCT) in Multiple Sclerosis
por: Young, Nicholas, et al.
Publicado: (2023)

Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI
por: Fuchs, Tom A., et al.
Publicado: (2021)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis
por: Caprio, Maria Grazia, et al.
Publicado: (2017)

Fitts’ Tapping Task as a New Test for Cognition and Manual Dexterity in Multiple Sclerosis: Validation Study
por: Glavor, Klaudia Duka, et al.
Publicado: (2022)

Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple Sclerosis
por: Ziliotto, Nicole, et al.
Publicado: (2020)

Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-β
por: Sternberg, Zohara, et al.
Publicado: (2009)

Current Status and Challenges Associated with Tick-Borne Pathogens and Diseases: Where Do We Stand?
por: Banović, Pavle, et al.
Publicado: (2023)

Detecting isolated cognitive relapses in persons with MS
por: Morrow, Sarah A, et al.
Publicado: (2023)

Cognitive Profiles of Aging in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2019)

Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Coagulation Pathways in Neurological Diseases: Multiple Sclerosis
por: Ziliotto, Nicole, et al.
Publicado: (2019)

Ketogenic diet: Predictors of seizure control
por: Agarwal, Nitin, et al.
Publicado: (2017)

Use of patient-reported data in determining factors contributing to internal jugular vein stenosis outcomes
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Editorial of Special Issue “Multiple Sclerosis: From Diagnostic Biomarkers to Imaging and Clinical Predictors”
por: Jakimovski, Dejan, et al.
Publicado: (2022)

Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2012)

Breakthrough COVID-19 infections – Analyzing our experience
por: Hussain, Aneela, et al.
Publicado: (2023)

Tick-Borne Encephalitis Virus and Borrelia burgdorferi Seroprevalence in Balkan Tick-Infested Individuals: A Two-Centre Study
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
por: Jakimovski, Dejan, et al.
Publicado: (2019)

Risk Factors for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in a Large Cohort of Volunteers
por: Dolic, Kresimir, et al.
Publicado: (2011)

Varicella outbreak in the patients during group therapy: seroprevalence in a healthcare system during breakthrough varicella occurrence
por: Park, Cheong Soo, et al.
Publicado: (2013)

Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic
por: Levit, Elle, et al.
Publicado: (2022)

Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data
por: Epstein, Samantha, et al.
Publicado: (2022)

A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection
por: Kim, Heui Man, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i9i1mct03t2j4ghi8rjajsgvp2